Published in Front Immunol on November 15, 2012
Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform. MAbs (2015) 0.81
Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives. Adv Biol (2014) 0.81
Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies. Proc Natl Acad Sci U S A (2015) 0.80
The functional repertoire of rabbit antibodies and antibody discovery via next-generation sequencing. MAbs (2014) 0.79
Reconciling the structural attributes of avian antibodies. J Biol Chem (2014) 0.78
The evolution and development of the antibody repertoire. Front Immunol (2015) 0.77
Predominant structural configuration of natural antibody repertoires enables potent antibody responses against protein antigens. Sci Rep (2015) 0.76
Epitope Mapping of Avian Influenza M2e Protein: Different Species Recognise Various Epitopes. PLoS One (2016) 0.75
A Novel Human scFv Library with Non-Combinatorial Synthetic CDR Diversity. PLoS One (2015) 0.75
A rapid live-cell ELISA for characterizing antibodies against cell surface antigens of Chlamydomonas reinhardtii and its use in isolating algae from natural environments with related cell wall components. BMC Plant Biol (2014) 0.75
Novel Structural Parameters of Ig-Ag Complexes Yield a Quantitative Description of Interaction Specificity and Binding Affinity. Front Immunol (2017) 0.75
Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 83.56
Somatic generation of antibody diversity. Nature (1983) 28.06
The immunoglobulin superfamily--domains for cell surface recognition. Annu Rev Immunol (1988) 12.87
The atomic structure of protein-protein recognition sites. J Mol Biol (1999) 12.63
Solvent-accessible surfaces of proteins and nucleic acids. Science (1983) 11.29
Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science (1985) 10.42
An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med (1970) 9.83
Phage antibodies: filamentous phage displaying antibody variable domains. Nature (1990) 8.67
Joining of immunoglobulin heavy chain gene segments: implications from a chromosome with evidence of three D-JH fusions. Proc Natl Acad Sci U S A (1982) 8.53
Naturally occurring antibodies devoid of light chains. Nature (1993) 7.35
Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem (2007) 6.92
By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol (1991) 6.62
Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol (1987) 6.42
Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Science (2001) 5.39
Conformations of immunoglobulin hypervariable regions. Nature (1990) 5.31
Selecting and screening recombinant antibody libraries. Nat Biotechnol (2005) 4.51
Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov (2010) 4.47
High-throughput sequencing of the zebrafish antibody repertoire. Science (2009) 4.46
A hyperconversion mechanism generates the chicken light chain preimmune repertoire. Cell (1987) 4.23
Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature (1986) 4.19
Early restriction of the human antibody repertoire. Science (1987) 3.90
Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J (1994) 3.68
Three-dimensional structure of immunoglobulins. Annu Rev Biochem (1979) 3.66
Anatomy of the antibody molecule. Mol Immunol (1994) 3.65
Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proc Natl Acad Sci U S A (2009) 3.56
IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res (2005) 3.46
Standard conformations for the canonical structures of immunoglobulins. J Mol Biol (1997) 3.42
Structural basis of antibody function. Annu Rev Immunol (1983) 3.41
Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U S A (1984) 3.32
Evolutionary and somatic selection of the antibody repertoire in the mouse. Science (1987) 3.29
The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol (1992) 3.19
Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity (1998) 3.16
Antibody-antigen interactions: new structures and new conformational changes. Curr Opin Struct Biol (1994) 2.95
High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. J Mol Biol (2007) 2.88
Structure, function and properties of antibody binding sites. J Mol Biol (1991) 2.84
Somatic hyperconversion diversifies the single Vh gene of the chicken with a high incidence in the D region. Cell (1989) 2.77
Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J Mol Biol (2000) 2.73
A single rearrangement event generates most of the chicken immunoglobulin light chain diversity. Cell (1985) 2.65
Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol (2007) 2.59
The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J Exp Med (1998) 2.56
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc Natl Acad Sci U S A (2006) 2.51
Antibody framework residues affecting the conformation of the hypervariable loops. J Mol Biol (1992) 2.44
Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes. J Exp Med (1998) 2.39
Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J Mol Biol (2003) 2.35
Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots. Proc Natl Acad Sci U S A (1993) 2.30
Marketed therapeutic antibodies compendium. MAbs (2012) 2.26
Antibody-antigen interactions: contact analysis and binding site topography. J Mol Biol (1996) 2.22
Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. Proc Natl Acad Sci U S A (2004) 2.17
High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. J Mol Biol (2004) 2.14
Length distribution of CDRH3 in antibodies. Proteins (1993) 2.12
Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J Immunol (1991) 2.11
Human anti-self antibodies with high specificity from phage display libraries. EMBO J (1993) 2.08
Somatic hypermutation. Curr Opin Immunol (1995) 2.08
Structural repertoire of the human VH segments. J Mol Biol (1992) 2.06
Immunoglobulin gene diversification. Annu Rev Genet (2005) 2.00
Rep-Seq: uncovering the immunological repertoire through next-generation sequencing. Immunology (2012) 1.99
Conformations of the third hypervariable region in the VH domain of immunoglobulins. J Mol Biol (1998) 1.96
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol (2009) 1.94
Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem. Proc Natl Acad Sci U S A (1992) 1.93
Camelid immunoglobulins and nanobody technology. Vet Immunol Immunopathol (2008) 1.90
Editors and editing of anti-DNA receptors. Immunity (2001) 1.90
The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions. MAbs (2010) 1.86
Molecular recognition by a binary code. J Mol Biol (2005) 1.85
Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis. Nucleic Acids Res (1994) 1.85
Attempts to locate complementarity-determining residues in the variable positions of light and heavy chains. Ann N Y Acad Sci (1971) 1.84
A new clustering of antibody CDR loop conformations. J Mol Biol (2010) 1.83
Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel. J Biol Chem (1998) 1.83
Crystal structure of a shark single-domain antibody V region in complex with lysozyme. Science (2004) 1.81
Biophysical properties of human antibody variable domains. J Mol Biol (2003) 1.80
Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J Mol Biol (1999) 1.75
Structural families in loops of homologous proteins: automatic classification, modelling and application to antibodies. J Mol Biol (1996) 1.71
Comparison of antibody repertoires produced by HIV-1 infection, other chronic and acute infections, and systemic autoimmune disease. PLoS One (2011) 1.68
Determinism and stochasticity during maturation of the zebrafish antibody repertoire. Proc Natl Acad Sci U S A (2011) 1.68
The importance of being tyrosine: lessons in molecular recognition from minimalist synthetic binding proteins. ACS Chem Biol (2009) 1.65
Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions. J Mol Biol (2004) 1.53
Structure and evolution of mammalian VH families. Int Immunol (1990) 1.53
Chicken immunoglobulin gamma-heavy chains: limited VH gene repertoire, combinatorial diversification by D gene segments and evolution of the heavy chain locus. EMBO J (1988) 1.53
Sequencing antibody repertoires: the next generation. MAbs (2011) 1.52
Computer-aided antibody design. Protein Eng Des Sel (2012) 1.44
A directory of human germ-line V kappa segments reveals a strong bias in their usage. Eur J Immunol (1994) 1.44
Structural classification of CDR-H3 in antibodies. FEBS Lett (1996) 1.43
Design, construction, and characterization of a large synthetic human antibody phage display library. Proteomics (2005) 1.42
The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies. J Mol Biol (2008) 1.41
Synthetic therapeutic antibodies. Nat Chem Biol (2006) 1.39
Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering. Methods (2004) 1.37
Humanization of antibodies. Front Biosci (2008) 1.35
Somatic hypermutation of human immunoglobulin heavy chain genes: targeting of RGYW motifs on both DNA strands. Eur J Immunol (1998) 1.35
Effects of charge on antibody tissue distribution and pharmacokinetics. Bioconjug Chem (2010) 1.32
The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies. J Biol Chem (2000) 1.32
Antibody modeling assessment. Proteins (2011) 1.30
Similarity and divergence in the development and expression of the mouse and human antibody repertoires. Dev Comp Immunol (2006) 1.27
The structural repertoire of the human V kappa domain. EMBO J (1995) 1.26
Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human VH domains. J Biol Chem (2007) 1.26
Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features. Mol Immunol (2000) 1.26
Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code. J Mol Biol (2005) 1.26
Antibody repertoire development in camelids. Dev Comp Immunol (2006) 1.23
Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C. Clin Cancer Res (2006) 1.23
Selection of human anti-hapten antibodies from semisynthetic libraries. Gene (1993) 1.23
Functional heavy-chain antibodies in Camelidae. Adv Immunol (2001) 1.22
Synthetic antibody libraries focused towards peptide ligands. J Mol Biol (2008) 1.15
Human framework adaptation of a mouse anti-human IL-13 antibody. J Mol Biol (2010) 0.97
De novo selection of high-affinity antibodies from synthetic fab libraries displayed on phage as pIX fusion proteins. J Mol Biol (2010) 0.97
Structure and specificity of an antibody targeting a proteolytically cleaved IgG hinge. Proteins (2014) 0.87
Sequence variability in the fibroin-H intron of domesticated and wild silk moths. Insect Biochem Mol Biol (2004) 0.75